RedcoolMedia favicon

Carl Zeiss Meditec AG | Financials: Q3-2021/22 | Markus We

Free download Carl Zeiss Meditec AG | Financials: Q3-2021/22 | Markus Weber, CEO and Justus Felix Wehmer, CFO video and edit with RedcoolMedia movie maker MovieStudio video editor online and AudioStudio audio editor onlin

This is the free video Carl Zeiss Meditec AG | Financials: Q3-2021/22 | Markus Weber, CEO and Justus Felix Wehmer, CFO that can be downloaded, played and edit with our RedcoolMedia movie maker MovieStudio free video editor online and AudioStudio free audio editor online

VIDEO DESCRIPTION:

Play, download and edit the free video Carl Zeiss Meditec AG | Financials: Q3-2021/22 | Markus Weber, CEO and Justus Felix Wehmer, CFO.

Welcome to seat11a, in today’s video we are presenting Markus Weber, CEO, and Justus Felix Wehmer, CFO of Carl Zeiss Meditech AG.

Markus and Justus will present the Financials: Q3-2021/22 of Carl Zeiss Meditech

▶️ Visit us: seat11a.com/

Company Profile
The Medical Technology activities of ZEISS are bundled under the umbrella of the MDAX- and TecDAX-listed company Carl Zeiss Meditec AG.

With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world in major markets. The company can also exploit the Carl Zeiss group`s powerful global distribution network.

Two Pillars of Business & Markets:
The main activities of Carl Zeiss Meditec AG are located in the field of Ophthalmology and Microsurgery
In Ophthalmology, the Company offers mainly products and solutions for the diagnosis and treatment of eye diseases, as well as systems and consumables for cataract, retinal and refractive surgery.
In Microsurgery the Carl Zeiss Meditec Group provides visualization solutions for minimally invasive surgical treatments.

Markets:
The Carl Zeiss Meditec Group has operations all over the world.
With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world’s most important markets.

Milestones & Innovations:
Research and development plays an important role within the Carl Zeiss Meditec Group.
Our objective is to enable our customers and physicians to continuously improve treatment results through improvements in efficiency and innovative new products

----------------------------
▶️ Visit us: seat11a.com/
----------------------------

▶️ Other videos:
Elevator Pitches: seat11a.com/media-type/elevator-pitch/
Company Presentations: seat11a.com/media-type/presentation/
Financial Results: seat11a.com/media-type/financials/
The Big Conversations: seat11a.com/media-type/conversation/
ESG Topics: seat11a.com/media-type/esg/
Product Highlights: seat11a.com/media-type/products/

-----------------------------
▶️ About seat11a:
Seat11a is the next-generation roadshow for listed companies. We democratize financial intelligence by offering listed companies an investor video platform to address their message to Institutional and Professional Investors anywhere, anytime.

✅ Disclaimer:
this publication is just for informational purposes only – it is not considered to give any investment advice! You agree to seat11a.com/legal/ and seat11a.com/imprint/

Download, play and edit free videos and free audios from Carl Zeiss Meditec AG | Financials: Q3-2021/22 | Markus Weber, CEO and Justus Felix Wehmer, CFO using RedcoolMedia.net web apps

Ad

Ad